Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018-Reference-Cited by-同舟云学术

Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018

Published:2019-02-28 Issue:9 Volume:24 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Brolund Alma¹²,Lagerqvist Nina³¹²,Byfors Sara²,Struelens Marc J⁴,Monnet Dominique L⁴,Albiger Barbara⁴,Kohlenberg Anke⁴,

Affiliation:

1. These authors contributed equally to this work

2. Public Health Agency of Sweden, Solna, Sweden

3. European Public Health Microbiology Training Programme (EUPHEM), European Centre for Disease Prevention and Control, Stockholm, Sweden

4. European Centre for Disease Prevention and Control, Stockholm, Sweden

Abstract

A survey on the epidemiological situation, surveillance and containment activities for carbapenemase-producing Enterobacteriaceae (CPE) was conducted in European countries in 2018. All 37 participating countries reported CPE cases. Since 2015, the epidemiological stage of CPE expansion has increased in 11 countries. Reference laboratory capability, dedicated surveillance and a specific national containment plan are in existence in 33, 27 and 14 countries, respectively. Enhanced control efforts are needed for CPE containment in Europe.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference20 articles.

1. The epidemiology of carbapenem-resistant Enterobacteriaceae: The impact and evolution of a global menace.;Logan;J Infect Dis,2017

2. Hospital outbreak of a colistin-resistant, NDM-1- and OXA-48-producing Klebsiella pneumoniae: high mortality from pandrug resistance.;Guducuoglu;Microb Drug Resist,2018

3. Characterization of extensively drug-resistant or pandrug-resistant sequence type 147 and 101 OXA-48-producing Klebsiella pneumoniae causing bloodstream infections in patients in an intensive care unit.;Avgoulea;Antimicrob Agents Chemother,2018

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic and epidemiological insight of an outbreak of carbapenemase-producing Enterobacterales in a Portuguese hospital with the emergence of the new KPC-124;Journal of Infection and Public Health;2024-03

2. One-year surveillance for hypervirulent Klebsiella pneumoniae detected carbapenem-resistant superbugs;Microbiology Spectrum;2024-01-30

3. Aztreonam-avibactam synergy, a validation and comparison of diagnostic tools;Frontiers in Microbiology;2023-11-29

4. Emergence and persistent spread of carbapenemase-producing Klebsiella pneumoniae high-risk clones in Greek hospitals, 2013 to 2022;Eurosurveillance;2023-11-23

5. Treatment of Resistant Gram-negative bacilli in children;Infectious Diseases Now;2023-11